City of Jacksonville v. Purdue Pharma L.P. et al
City of Jacksonville |
Purdue Pharma L.P, Allergan PLC, Actavis Inc, Actavis Pharma, Inc., Purdue Pharma L.P. Manufacturer Defendants doing business as Purdue Pharma (Delaware) Limited Partnership, PURDUE PHARMA, INC., The Purdue Frederick Company Inc., Teva Pharmaceuticals USA, Inc., Cephalon, Inc., JANSSEN PHARMACEUTICALS, INC., Janssen Pharmaceutica Inc., ORTHO- MCNEIL-JANSSEN PHARMACEUTICALS, INC. nka JANSSEN PHARMACEUTICALS, INC., ENDO HEALTH SOLUTIONS INC., Endo Pharmaceuticals, Inc., Actavis PLC, Watson Pharmaceutcals, Inc., Watson Laboratories, Inc., Actavis LLC, Watson Pharma, Inc., Insys Therapeutics, Inc., McKesson Corporation, Cardinal Health, Inc., Amerisourcebergen Drug Corporation, Anda, Inc., John N. Kapoor, Michael Babich, Alec Burlakoff, Karen Hill, Joseph Rowan, ALLERGAN PLC F/K/A ACTAVIS PLS and Allergan Finance LLC |
FLM/3:18-CV-00751 |
June 12, 2018 |
Judicial Panel on Multidistrict Litigation |
Timothy J Corrigan |
Other |
Docket Report
This docket was last retrieved on April 8, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 47 ***TEXT ONLY ORDER***MINUTE ORDER SUSPENDING RULE 7.1(a) -- Pursuant to the Panel's order dated 4/8/22, document #9586 in MDL No. 2804. Notification of tag -alongs to the Clerk of the Panel is suspended until further notice.Signed by Clerk of the Panel John W. Nichols on 4/8/2022. Associated Cases: MDL No. 2804 et al. (dld) |
Filing 46 TRANSFER ORDER re: pldg. (4 in FLM/3:18-cv-00751, #1905 in MDL No. 2804), (41 in FLM/3:18-cv-00751, 45 in FLN/1:18-cv-00100, 38 in FLS/9:18-cv-80749, 40 in GAS/4:18-cv-00136, #2223 in MDL No. 2804, 30 in NJ/2:18-cv-10842, 33 in NJ/3:18-cv-10901, 37 in WIW/3:18-cv-00380), (42 in FLN/1:18-cv-00100, #1982 in MDL No. 2804), (34 in FLS/9:18-cv-80749, #2048 in MDL No. 2804), (19 in GAS/4:18-cv-00136, #1929 in MDL No. 2804), ( #2095 in MDL No. 2804, 31 in NJ/3:18-cv-10901), ( #1866 in MDL No. 2804, 11 in WIW/3:18-cv-00380), ( #2088 in MDL No. 2804, 24 in NJ/2:18-cv-10842) Transferring 7 action(s) - MDL No. 2804, FLM/3:18-cv-00751, FLN/1:18-cv-00100, FLS/9:18-cv-80749, GAS/4:18-cv-00136, NJ/2:18-cv-10842, NJ/3:18-cv-10901, WIW/3:18-cv-00380Signed by Judge Sarah S. Vance, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 10/3/2018. Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLN/1:18-cv-00100, FLS/9:18-cv-80749, GAS/4:18-cv-00136, NJ/2:18-cv-10842, NJ/3:18-cv-10901, WIW/3:18-cv-00380 (CMD) |
Filing 45 CORPORATE DISCLOSURE STATEMENT re: pldg. (3 in FLM/3:18-cv-00751, #1904 in MDL No. 2804) -- Identifying Corporate Parent AmerisourceBergen Services Corporation, Corporate Parent AMERISOURCEBERGEN CORPORATION for Amerisourcebergen Drug Corporation. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (Nicholas, Robert) |
Filing 44 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, #1848 in MDL No. 2804) Filed by Robert Arthur Nicholas on behalf of Defendant Amerisourcebergen Drug Corporation (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (Nicholas, Robert) |
Filing 43 ORAL ARGUMENT STATEMENT re: pldg. ( #2280 in MDL No. 2804) Filed by Defendant McKesson Corporation (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (Jessee, Russell) |
Filing 42 ORAL ARGUMENT STATEMENT re: pldg. ( 1904 in MDL No. 2804) Filed by Plaintiff City of Jacksonville (Attachments: #1 Exhibit A, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (SCOLNICK, JUDITH) ADDED MDL LINK Modified on 8/30/2018 (CMD). |
Filing 41 HEARING ORDER re: pldg. (4 in FLM/3:18-cv-00751, #1905 in MDL No. 2804), (42 in FLN/1:18-cv-00100, #1982 in MDL No. 2804), (34 in FLS/9:18-cv-80749, #2048 in MDL No. 2804), (26 in GAS/4:18-cv-00136, #1948 in MDL No. 2804), (19 in GAS/4:18-cv-00136, #1929 in MDL No. 2804), ( #2095 in MDL No. 2804, 31 in NJ/3:18-cv-10901), ( #1866 in MDL No. 2804, 11 in WIW/3:18-cv-00380), ( #2088 in MDL No. 2804, 24 in NJ/2:18-cv-10842), ( #2196 in MDL No. 2804, 27 in SC/8:18-cv-01947) in the following opposition(s) of Certain plaintiffs and defendants Curtis V. Cooper Primary Health Care, Inc., et al. in 8 Actions - FLM-1, FLN-1, FLS-1, GAS-1, NJ-2, SC-1, WIW-1 - SECTION B (DESIGNATED FOR CONSIDERATION WITHOUT ORAL ARGUMENT) PANEL HEARING set for 9/27/2018 in San Francisco, California.Signed by Judge Sarah S. Vance, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 8/16/2018. Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLN/1:18-cv-00100, FLS/9:18-cv-80749, GAS/4:18-cv-00136, NJ/2:18-cv-10842, NJ/3:18-cv-10901, SC/8:18-cv-01947, WIW/3:18-cv-00380 (RH) |
Filing 40 REPLY TO RESPONSE TO MOTION TO VACATE CTO-41 re: pldg. (39 in FLM/3:18-cv-00751, #2100 in MDL No. 2804), (4 in FLM/3:18-cv-00751, #1905 in MDL No. 2804), (38 in FLM/3:18-cv-00751, #2098 in MDL No. 2804) Filed by Plaintiff City of Jacksonville (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (SCOLNICK, JUDITH) |
Filing 39 RESPONSE IN OPPOSITION TO MOTION TO VACATE CTO (re: pldg. (4 in FLM/3:18-cv-00751, 1905 in MDL No. 2804), (34 in FLS/9:18-cv-80749, 2048 in MDL No. 2804) ) (CTO-41) Filed by Defendants Actavis Pharma, Inc., #et al.Actavis, LLC., Allergan Finance LLC, f/k/a Actavis Inc, f/k/a Watson Pharmaceuticals, Inc., Allergan plc f/k/a Actavis plc, Cephalon, Inc., Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., Insys Therapeutics, Inc., Janssen Pharmaceutica, Inc., Johnson & Johnson, Mallinckrodt LLC, Ortho-McNeil-Janssen Pharmaceuticals, Inc, Purdue Pharma Inc., Purdue Pharma L.P., Teva Pharmaceuticals USA, Inc. #[Suppress List] (Attachments: #1 Proof of Service, #2 Service List) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Reed, Steven) DELETED DUPLICATE PARTIES Modified on 7/24/2018 (CMD). |
Filing 38 Joint RESPONSE IN OPPOSITION TO MOTION TO VACATE CTO (re: pldg. (4 in FLM/3:18-cv-00751, #1905 in MDL No. 2804), (3 in FLM/3:18-cv-00751, #1904 in MDL No. 2804) ) (CTO-41) Filed by Defendants Cardinal Health, Inc., McKesson Corporation (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (Mainigi, Enu) |
Filing 37 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. ( 1848 in MDL No. 2804, 1 in FLM/3:18-cv-00751) Filed by Eric McKay on behalf of Defendant Joseph Rowan Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (McKay, Eric) ADDED MDL LINK Modified on 7/17/2018 (CMD). |
Filing 36 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. ( 1848 in MDL No. 2804, 1 in FLM/3:18-cv-00751) Filed by Thomas A Delegal, III on behalf of Defendant Karen Hill Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (Delegal, Thomas) ADDED MDL LINK Modified on 7/17/2018 (CMD). |
Filing 35 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. ( 1848 in MDL No. 2804, 1 in FLM/3:18-cv-00751) Filed by Philip Matthew Luka on behalf of Defendant Michael Babich (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (Luka, Philip) ADDED MDL LINK Modified on 7/17/2018 (CMD). |
Filing 34 CORPORATE DISCLOSURE STATEMENT re: pldg. (3 in FLM/3:18-cv-00751, 1904 in MDL No. 2804), (3 in FLS/9:18-cv-80749, 1857 in MDL No. 2804) -- Identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for ANDA, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Matthews, James) DELETED DUPLICATE PARTY Modified on 7/17/2018 (CMD). |
Filing 33 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, 1 in FLS/9:18-cv-80749, 1848 in MDL No. 2804) Filed by James W. Matthews on behalf of Defendant ANDA, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Matthews, James) DELETED DUPLICATE PARTY Modified on 7/17/2018 (CMD). |
Filing 32 CORPORATE DISCLOSURE STATEMENT re: pldg. (3 in FLS/9:18-cv-80749) -- Identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Lifland, Charles) |
Filing 31 CORPORATE DISCLOSURE STATEMENT re: pldg. (3 in FLS/9:18-cv-80749) -- Identifying Corporate Parent No Parent Corp. for Johnson & Johnson. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Lifland, Charles) |
Filing 30 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, 1 in FLS/9:18-cv-80749, #1848 in MDL No. 2804) Filed by Charles Coleman Lifland on behalf of Defendants Janssen Pharmaceutica, Inc., #et al.Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc, Janssen Pharmaceuticals, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Lifland, Charles) |
Filing 29 CORPORATE DISCLOSURE STATEMENT re: pldg. (3 in FLM/3:18-cv-00751, 1904 in MDL No. 2804), (3 in FLS/9:18-cv-80749, 1857 in MDL No. 2804) -- Identifying Corporate Parent Allergan plc for Allergan Finance LLC, f/k/a Actavis Inc, f/k/a Watson Pharmaceuticals, Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Welch, Donna) DELETED DUPLICATE PARTY Modified on 7/17/2018 (CMD). |
Filing 28 CORPORATE DISCLOSURE STATEMENT re: pldg. (3 in FLM/3:18-cv-00751, 1904 in MDL No. 2804), (3 in FLS/9:18-cv-80749, 1857 in MDL No. 2804) -- Identifying Corporate Parent No Parent Corp. for Allergan plc f/k/a Actavis plc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Welch, Donna) DELETED DUPLICATE PARTY Modified on 7/17/2018 (CMD). |
Filing 27 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, 1 in FLS/9:18-cv-80749, 1848 in MDL No. 2804) Filed by Donna Marie Welch on behalf of Defendants Allergan plc f/k/a Actavis plc, #et al.Allergan plc f/k/a Actavis plc, Allergan Finance LLC, f/k/a Actavis Inc, f/k/a Watson Pharmaceuticals, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Welch, Donna) DELETED DUPLICATE PARTIES Modified on 7/17/2018 (CMD). |
Filing 26 CORPORATE DISCLOSURE STATEMENT re: pldg. (3 in FLM/3:18-cv-00751, 1904 in MDL No. 2804), (3 in FLS/9:18-cv-80749, 1857 in MDL No. 2804) -- Identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Attachments: #1 Supplement, #2 Proof of Service, #3 Service List) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Reed, Steven) DELETED DUPLICATE PARTIES Modified on 7/17/2018 (CMD). |
Filing 25 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, 1 in FLS/9:18-cv-80749, 1848 in MDL No. 2804) Filed by Steven A. Reed on behalf of Defendants Actavis Pharma, Inc., #et al.Actavis, LLC., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. #[Suppress List] (Attachments: #1 Proof of Service, #2 Service List) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Reed, Steven) DELETED DUPLICATE PARTIES Modified on 7/17/2018 (CMD). |
Filing 24 CORPORATE DISCLOSURE STATEMENT re: pldg. (3 in FLM/3:18-cv-00751, 1904 in MDL No. 2804), (3 in FLS/9:18-cv-80749, 1857 in MDL No. 2804) -- Identifying Corporate Parent No Parent Corp. for McKesson Corporation. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Jessee, Russell) DELETED DUPLICATE PARTY Modified on 7/16/2018 (CMD). |
Filing 23 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, 1 in FLS/9:18-cv-80749, 1848 in MDL No. 2804) Filed by Russell David Jessee on behalf of Defendants HealthMart Systems, Inc., #et al.McKesson Corporation #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Jessee, Russell) DELETED DUPLICATE PARTY Modified on 7/16/2018 (CMD). |
Filing 22 CORPORATE DISCLOSURE STATEMENT re: pldg. (3 in FLM/3:18-cv-00751), (3 in FLS/9:18-cv-80749) -- Identifying Corporate Parent Endo International plc for Endo Health Solutions Inc., Endo Pharmaceuticals, Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Stern, Jonathan) |
Filing 21 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, 1 in FLS/9:18-cv-80749, 1848 in MDL No. 2804) Filed by Jonathan L. Stern on behalf of Defendants Endo Health Solutions, Inc., #et al.Endo Pharmaceuticals, Inc. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Stern, Jonathan) DELETED DUPLICATE PARTIES Modified on 7/16/2018 (CMD). |
Filing 20 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, #1848 in MDL No. 2804) Filed by Kurt Michael Mullen on behalf of Defendant John Kapoor (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (Mullen, Kurt) |
Filing 19 DUPLICATE PLDG. SEE PLDG. 2022DOCUMENT (AMENDED) - Amendment to ( 2022 IN MDL No. 2804, 17 in FLM/3:18-cv-00751) Notice of Appearance (CTO), Filed by Plaintiff City of Jacksonville (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (SCOLNICK, JUDITH) Modified on 7/16/2018 (CMD). |
Filing 18 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (12 in FLM/3:18-cv-00751, 8 in FLS/9:18-cv-80749, 2015 in MDL No. 2804), (11 in FLM/3:18-cv-00751, 7 in FLS/9:18-cv-80749, 2014 in MDL No. 2804) Filed by Defendants Insys Therapeutics, Inc. -- Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Donohue, J.) DELETED DUPLICATE PARTY Modified on 7/16/2018 (CMD). |
Filing 17 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, #1848 in MDL No. 2804) Filed by JUDITH S. SCOLNICK on behalf of Plaintiff City of Jacksonville (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (SCOLNICK, JUDITH) |
Filing 16 CORPORATE DISCLOSURE STATEMENT re: pldg. (4 in FLM/3:18-cv-00751, 1905 in MDL No. 2804), (3 in FLM/3:18-cv-00751, 1904 in MDL No. 2804), (3 in FLS/9:18-cv-80749, 1857 in MDL No. 2804) -- Identifying Corporate Parent Pharmaceutical Research Associates, Inc. for The Purdue Frederick Company, Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Cheffo, Mark) DELETED DUPLICATE PARTY Modified on 7/16/2018 (CMD). |
Filing 15 CORPORATE DISCLOSURE STATEMENT re: pldg. (4 in FLM/3:18-cv-00751, 1905 in MDL No. 2804), (3 in FLM/3:18-cv-00751, 1904 in MDL No. 2804), (3 in FLS/9:18-cv-80749, 1857 in MDL No. 2804) -- Identifying Corporate Parent No Parent Corp. for Purdue Pharma Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Cheffo, Mark) DELETED DUPLICATE PARTY Modified on 7/16/2018 (CMD). |
Filing 14 CORPORATE DISCLOSURE STATEMENT re: pldg. (4 in FLM/3:18-cv-00751, 1905 in MDL No. 2804), (3 in FLM/3:18-cv-00751, 1904 in MDL No. 2804), (3 in FLS/9:18-cv-80749, 1857 in MDL No. 2804) -- Identifying Corporate Parent No Parent Corp. for Purdue Pharma L.P.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Cheffo, Mark) DELETED DUPLICATE PARTY Modified on 7/16/2018 (CMD). |
Filing 13 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, 1 in FLS/9:18-cv-80749, 1848 in MDL No. 2804) Filed by Mark Steven Cheffo on behalf of Defendants Purdue Pharma Inc., #et al.Purdue Pharma L.P., The Purdue Frederick Company, Inc.. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Cheffo, Mark) DELETED DUPLICATE PARTIES Modified on 7/16/2018 (CMD). |
Filing 12 CORPORATE DISCLOSURE STATEMENT re: pldg. (3 in FLM/3:18-cv-00751, 1904 in MDL No. 2804), (3 in FLS/9:18-cv-80749, 1857 in MDL No. 2804) -- Identifying Corporate Parent No Parent Corp. for Insys Therapeutics, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Donohue, J.) ADDED CORPORATE PARENT Modified on 7/16/2018 (CMD). |
Filing 11 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, 1 in FLS/9:18-cv-80749, 1848 in MDL No. 2804) Filed by J. Matthew Donohue on behalf of Defendant Insys Therapeutics, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Donohue, J.) DELETED DUPLICATE PARTY Modified on 7/16/2018 (CMD). |
Filing 10 CORPORATE DISCLOSURE STATEMENT re: pldg. (4 in FLM/3:18-cv-00751, 1905 in MDL No. 2804), (3 in FLM/3:18-cv-00751, 1904 in MDL No. 2804), (5 in FLM/3:18-cv-00751, 1906 in MDL No. 2804), (3 in FLS/9:18-cv-80749, 1857 in MDL No. 2804) -- Identifying Corporate Parent No Parent Corp. for Cardinal Health, Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Mainigi, Enu) DELETED DUPLICATE PARTY Modified on 7/16/2018 (CMD). |
Filing 9 NOTICE OF APPEARANCE FOR CTO-41 re: pldg. (1 in FLM/3:18-cv-00751, 1 in FLS/9:18-cv-80749, 1848 in MDL No. 2804) Filed by Enu Mainigi on behalf of Defendant Cardinal Health, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (Mainigi, Enu) DELETED DUPLICATE PARTY Modified on 7/16/2018 (CMD). |
Filing 8 CERTIFICATE OF SERVICE (AMENDED) re: pldg. ( #1905 in MDL No. 2804), ( #1904 in MDL No. 2804) Filed by Plaintiff City of Jacksonville -- (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (SCOLNICK, JUDITH) |
Filing 7 ***TEXT ONLY NOTICE***NOTICE OF FILED OPPOSITIONS TO CTO-41 WITH MOTION AND BRIEF AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. (4 in FLM/3:18-cv-00751, #1905 in MDL No. 2804), (3 in FLM/3:18-cv-00751, #1904 in MDL No. 2804), (3 in FLS/9:18-cv-80749, #1857 in MDL No. 2804) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 7/16/2018. Corporate Disclosure Statements due on or before 7/16/2018. Motion and Brief for Plaintiff Palm Beach County due on or before 7/16/18. Consolidated Responses due on or before 7/23/2018. #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Signed by Clerk of the Panel Jeffery N. Luthi on 7/2/2018. Associated Cases: MDL No. 2804, FLM/3:18-cv-00751, FLS/9:18-cv-80749 (CMD) |
Filing 6 ***TEXT ONLY ENTRY***MINUTE ORDER (re: pldg. (5 in FLM/3:18-cv-00751, #1906 in MDL No. 2804) ) Motion to Delay Transfer filed by Plaintiff City of Jacksonville is DENIED. This matter will be heard in due course. Signed by Clerk of the Panel Jeffery N. Luthi on 7/2/2018. Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (JN) |
Filing 5 MOTION Delay of Transfer for 120 Days or Until October 22, 2018 re: pldg. ( #1848 in MDL No. 2804) - Filed by JUDITH S. SCOLNICK on behalf of Plaintiff City of Jacksonville Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (SCOLNICK, JUDITH) |
Filing 4 MOTION TO VACATE CONDITIONAL TRANSFER ORDER WITH BRIEF IN SUPPORT (CTO-41) re: pldg. (3 in FLM/3:18-cv-00751, #1904 in MDL No. 2804) Filed by Plaintiff City of Jacksonville (Attachments: #1 Brief, #2 Declaration, #3 Exhibit A, #4 Exhibit B, #5 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (SCOLNICK, JUDITH) |
Filing 3 NOTICE OF OPPOSITION TO CONDITIONAL TRANSFER ORDER (CTO-41) - 1 action(s) - re: pldg. (1 in FLM/3:18-cv-00751, #1848 in MDL No. 2804) Filed by Plaintiff City of Jacksonville (Attachments: #1 Proof of Service) Associated Cases: MDL No. 2804, FLM/3:18-cv-00751 (SCOLNICK, JUDITH) |
Filing 2 ***TEXT ONLY NOTICE***NOTICE OF FILING OF CTO AND PUBLICATION OF BRIEFING SCHEDULE (CTO-41) re: pldg. (1 in ALN/1:18-cv-00819, 1 in ALN/1:18-cv-00820, 1 in FLM/3:18-cv-00751, 1 in FLM/6:18-cv-00944, 1 in FLS/9:18-cv-80749, 1 in KS/2:18-cv-02311, 1 in KS/2:18-cv-02312, 1 in MA/1:18-cv-11207, 1 in MA/1:18-cv-11208, 1 in MA/1:18-cv-11219, 1 in MA/1:18-cv-11223, 1 in MA/3:18-cv-30088, 1 in MA/4:18-cv-40098, 1 in MA/4:18-cv-40100, #1848 in MDL No. 2804, 1 in MOW/5:18-cv-06084, 2 in NM/1:18-cv-00534, 2 in WVS/2:18-cv-01008) BRIEFING SCHEDULE IS SET AS FOLLOWS: Oppositions due on or before 6/29/2018. Signed by Clerk of the Panel Jeffery N. Luthi on 6/22/2018. Associated Cases: MDL No. 2804, ALN/1:18-cv-00819, ALN/1:18-cv-00820, FLM/3:18-cv-00751, FLM/6:18-cv-00944, FLS/9:18-cv-80749, KS/2:18-cv-02311, KS/2:18-cv-02312, MA/1:18-cv-11207, MA/1:18-cv-11208, MA/1:18-cv-11219, MA/1:18-cv-11223, MA/3:18-cv-30088, MA/4:18-cv-40098, MA/4:18-cv-40100, MOW/5:18-cv-06084, NM/1:18-cv-00534, WVS/2:18-cv-01008 (CMD) |
Filing 1 CONDITIONAL TRANSFER ORDER FILED TODAY (CTO-41) - 17 action(s) Signed by Clerk of the Panel Jeffery N. Luthi on 6/22/2018. Associated Cases: MDL No. 2804, ALN/1:18-cv-00819, ALN/1:18-cv-00820, FLM/3:18-cv-00751, FLM/6:18-cv-00944, FLS/9:18-cv-80749, KS/2:18-cv-02311, KS/2:18-cv-02312, MA/1:18-cv-11207, MA/1:18-cv-11208, MA/1:18-cv-11219, MA/1:18-cv-11223, MA/3:18-cv-30088, MA/4:18-cv-40098, MA/4:18-cv-40100, MOW/5:18-cv-06084, NM/1:18-cv-00534, WVS/2:18-cv-01008 (CMD) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.